Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

Abstract:

:Loss of chromosome 19p is one of the most frequent allelic imbalances in esophageal squamous cell carcinoma (ESCC), suggesting the existence of one or more tumor suppressor genes within this region. In this study, we investigated a role in ESCCs for a candidate tumor suppressor gene located at 19p13.3, the Ras-like small GTPase DIRAS1. Downregulation of DIRAS1 occurred in approximately 50% of primary ESCCs where it was associated significantly with advanced clinical stage, lymph node metastasis, and poor overall survival. LOH and promoter methylation analyses suggested that loss of DIRAS1 expression was mediated by epigenetic mechanisms. Functional studies established that ectopic re-expression of DIRAS1 in ESCC cells inhibited cell proliferation, clonogenicity, cell motility, and tumor formation. Mechanistic investigations suggested that DIRAS1 acted through extracellular signal-regulated kinase (ERK1/2; MAPK3/1) and p38 mitogen-activated protein kinase (MAPK; MAPK14) signaling to trigger BAD Ser112 dephosphorylation and matrix metalloproteinase (MMP)2/9 transcriptional inactivation to promote apoptosis and inhibit metastasis, respectively. Taken together, our results revealed that DIRAS1 has a pivotal function in ESCC pathogenesis, with possible use as a biomarker and intervention point for new therapeutic strategies.

journal_name

Cancer Res

journal_title

Cancer research

authors

Zhu YH,Fu L,Chen L,Qin YR,Liu H,Xie F,Zeng T,Dong SS,Li J,Li Y,Dai Y,Xie D,Guan XY

doi

10.1158/0008-5472.CAN-12-2663

subject

Has Abstract

pub_date

2013-04-01 00:00:00

pages

2298-309

issue

7

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-12-2663

journal_volume

73

pub_type

杂志文章
  • Differential activation and inhibition of lymphocyte proliferation by phorbol esters, mezerein, teleocidin, and okadaic acid.

    abstract::Lymphocytes can be stimulated to proliferate in vitro by mitogens such as concanavalin A. The tumor-promoting phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) can enhance this proliferation, partly because of an increase in interleukin 2 (IL-2) production. However, if lymphocytes are treated with TPA for 24 h...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grove DS,Mastro AM

    更新日期:1991-01-01 00:00:00

  • Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury.

    abstract::Inflammation is a critical player in the development of both colitis-associated and sporadic colon cancers. Several studies suggest that the microbiota contribute to inflammation and tumorigenesis; however, studies to understand the role of the microbiota in colon tumor development in germ-free (GF) mice are limited. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0827

    authors: Zhan Y,Chen PJ,Sadler WD,Wang F,Poe S,Núñez G,Eaton KA,Chen GY

    更新日期:2013-12-15 00:00:00

  • JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.

    abstract::Hypoxia-inducible factor-1alpha (HIF-1alpha) is a master transcription factor that is critical for the regulation of a variety of cellular functions. HIF-1alpha is rapidly degraded under normoxic conditions by ubiquitin-mediated proteasome pathway controlled by the tumor suppressor von Hippel Lindau (VHL). Several rec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0448

    authors: Zhang D,Li J,Costa M,Gao J,Huang C

    更新日期:2010-01-15 00:00:00

  • ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

    abstract::Two opposing clusters of transcription factors (TF) have been associated with the differential risks of estrogen receptor positive or negative breast cancers, but the mechanisms underlying the opposing functions of the two clusters are undefined. In this study, we identified NFIB and YBX1 as novel interactors of the e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1153

    authors: Campbell TM,Castro MAA,de Oliveira KG,Ponder BAJ,Meyer KB

    更新日期:2018-01-15 00:00:00

  • BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

    abstract::SWI/SNF chromatin remodeling complexes regulate critical cellular processes, including cell-cycle control, programmed cell death, differentiation, genomic instability, and DNA repair. Inactivation of this class of chromatin remodeling complex has been associated with a variety of malignancies, including lung, ovarian,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0061

    authors: Orvis T,Hepperla A,Walter V,Song S,Simon J,Parker J,Wilkerson MD,Desai N,Major MB,Hayes DN,Davis IJ,Weissman B

    更新日期:2014-11-15 00:00:00

  • Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis.

    abstract::Crosstalk between tumor and stromal cells in the tumor microenvironment alter its properties in ways that facilitate the invasive behavior of tumor cells. Here, we demonstrate that cancer-associated fibroblasts (CAF) increase the stiffness of the extracellular matrix (ECM) and promote anisotropic fiber orientation, tw...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1903

    authors: Stanisavljevic J,Loubat-Casanovas J,Herrera M,Luque T,Peña R,Lluch A,Albanell J,Bonilla F,Rovira A,Peña C,Navajas D,Rojo F,García de Herreros A,Baulida J

    更新日期:2015-01-15 00:00:00

  • Enhancement of biochemical transformation of mammalian cells by herpes simplex virus following nitrosomethylurea treatment.

    abstract::A quantitative assay for the biochemical transformation of thymidine kinaseless mouse cells (N cIA cI10 cells) to an enzyme-positive phenotype by herpes simplex virus has been used to examine the effect of the carcinogen nitrosomethylurea on cell transformation. Exposure of cells to the chemical carcinogen, followed b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Howett MK,Pegg AE,Rapp F

    更新日期:1979-03-01 00:00:00

  • DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

    abstract::The DNA of L1210 cells exposed to low concentrations of 1-(2-chloroethyl)=3-cyclohexyl-1-nitrosourea has been analyzed for the presence of single-strand breaks. DNA from 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea-treated cells both sediments more slowly than control DNA on alkaline sucrose gradients andshows a great...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hilton J,Bowie DL,Gutin PH,Zito DM,Walker MD

    更新日期:1977-07-01 00:00:00

  • Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.

    abstract::Low-level methotrexate (MTX) resistance (less than 20-fold) was induced by gradual selection pressure in four human head and neck squamous cell carcinoma lines established in culture from biopsies of patients not previously treated with MTX. Each parental and resistant line was characterized with respect to MTX uptake...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosowsky A,Wright JE,Cucchi CA,Lippke JA,Tantravahi R,Ervin TJ,Frei E 3rd

    更新日期:1985-12-01 00:00:00

  • Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.

    abstract::Anthracycline, either daunomycin or doxorubicin, was site specifically attached to the carbohydrate moiety of a monoclonal anticarcinoembryonic antigen antibody by using amino-dextran as the intermediate carrier. The reaction resulted in an immunoconjugate that contains approximately 20 to 25 molecules of drug per mol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shih LB,Goldenberg DM,Xuan H,Lu H,Sharkey RM,Hall TC

    更新日期:1991-08-15 00:00:00

  • Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.

    abstract::Multi-targeting strategies improve the efficacy of antibody and immunotoxin therapies but have not yet been thoroughly explored for HER2-based cancer treatments. We investigated multi-epitope HER2 targeting to boost photosensitizer immunoconjugate uptake as a way of enhancing photoimmunotherapy. Photoimmunotherapy may...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0426

    authors: Savellano MD,Pogue BW,Hoopes PJ,Vitetta ES,Paulsen KD

    更新日期:2005-07-15 00:00:00

  • Exploiting DNA Replication Stress for Cancer Treatment.

    abstract::Complete and accurate DNA replication is fundamental to cellular proliferation and genome stability. Obstacles that delay, prevent, or terminate DNA replication cause the phenomena termed DNA replication stress. Cancer cells exhibit chronic replication stress due to the loss of proteins that protect or repair stressed...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-3631

    authors: Ubhi T,Brown GW

    更新日期:2019-04-15 00:00:00

  • Hormone binding by human mammary carcinoma.

    abstract::The specific binding of labeled porcine insulin, human prolactin, and human growth hormone was studied in 63 human breast tumors and 15 nonmalignant breast tissues. Most (90%) of the tumors demonstrated significant binding of insulin, as did 80% of nonmalignant tissues. Autoradiographic studies indicated that insulin ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holdaway IM,Friesen HG

    更新日期:1977-07-01 00:00:00

  • SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.

    abstract::The therapeutic potential of cisplatin, one of the most active and widely used anticancer drugs, is severely limited by the occurrence of cellular resistance. In this study, using budding yeast Saccharomyces cerevisiae as a model organism to identify novel drug resistance genes, we found that disruption of the yeast g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schenk PW,Boersma AW,Brandsma JA,den Dulk H,Burger H,Stoter G,Brouwer J,Nooter K

    更新日期:2001-10-01 00:00:00

  • Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

    abstract::Lymphangioleiomyomatosis (LAM) is a progressive destructive neoplasm of the lung associated with inactivating mutations in the TSC1 or TSC2 tumor suppressor genes. Cell or animal models that accurately reflect the pathology of LAM have been challenging to develop. Here, we generated a robust human cell model of LAM by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0925

    authors: Julian LM,Delaney SP,Wang Y,Goldberg AA,Doré C,Yockell-Lelièvre J,Tam RY,Giannikou K,McMurray F,Shoichet MS,Harper ME,Henske EP,Kwiatkowski DJ,Darling TN,Moss J,Kristof AS,Stanford WL

    更新日期:2017-10-15 00:00:00

  • Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).

    abstract::7-Hydroxystaurosporine (UCN-01) is a protein kinase inhibitor that is under development as an anticancer agent in the United States and Japan. Long-term exposure of human A549 non-small cell lung cancer cells to UCN-01 furnished cells (A549/UCN) with acquired resistance against UCN-01. In this study, the sensitivity o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sugiyama K,Akiyama T,Shimizu M,Tamaoki T,Courage C,Gescher A,Akinaga S

    更新日期:1999-09-01 00:00:00

  • Temperature-dependent influence of thiols upon glutathione levels in Chinese hamster ovary cells at cytotoxic concentrations.

    abstract::Chinese hamster ovary cells were exposed to the sulfhydryl compound cysteamine at different temperatures (5 degrees C, 37 degrees C, 44 degrees C) at concentrations known to generate activated oxygen species. At 37 degrees C, the cellular glutathione (GSH) content increased linearly over the time of drug exposure (2 h...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Issels RD,Bourier S,Biaglow JE,Gerweck LE,Wilmanns W

    更新日期:1985-12-01 00:00:00

  • Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells.

    abstract::The influence of gangliosides on tumor growth and frequency of metastasis in vivo as well as on growth and motility of neoplastic cells in vitro was tested utilizing human and rodent cell populations. In mice receiving injections of a ganglioside mixture twice daily the tumor volume, the number of spontaneous metastas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alessandri G,Filippeschi S,Sinibaldi P,Mornet F,Passera P,Spreafico F,Cappa PM,Gullino PM

    更新日期:1987-08-15 00:00:00

  • Calcium Promotes Human Gastric Cancer via a Novel Coupling of Calcium-Sensing Receptor and TRPV4 Channel.

    abstract::Although dietary calcium intake has long been recommended for disease prevention, the influence of calcium in development of cancer in the upper gastrointestinal tract has not been explored. Here, we assess the roles of calcium and calcium-sensing receptor (CaSR) in gastric cancer development. CaSR expression was enha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0360

    authors: Xie R,Xu J,Xiao Y,Wu J,Wan H,Tang B,Liu J,Fan Y,Wang S,Wu Y,Dong TX,Zhu MX,Carethers JM,Dong H,Yang S

    更新日期:2017-12-01 00:00:00

  • Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.

    abstract::We have shown that cyclophosphamide (CY) can augment the development of delayed-type hypersensitivity to a primary antigen in patients with advanced cancer. In the present study, we administered CY (1000 mg/sq m) to 19 patients with advanced, metastatic cancer and monitored the compositional and functional changes in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berd D,Maguire HC Jr,Mastrangelo MJ

    更新日期:1984-03-01 00:00:00

  • Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.

    abstract::R115777 [(B)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)-methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone] is a potent and selective inhibitor of farnesyl protein transferase with significant antitumor effects in vivo subsequent to oral administration in mice. In vitro, using isolated human farnesyl prote...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: End DW,Smets G,Todd AV,Applegate TL,Fuery CJ,Angibaud P,Venet M,Sanz G,Poignet H,Skrzat S,Devine A,Wouters W,Bowden C

    更新日期:2001-01-01 00:00:00

  • Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.

    abstract::The development of molecular dosimetry methods will simplify the identification of people at high risk for cancer. A combined monoclonal antibody immunoaffinity chromatography/high performance liquid chromatography method has been devised to isolate and quantify aflatoxin-DNA adducts and other metabolites in rat urine...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Groopman JD,Hasler JA,Trudel LJ,Pikul A,Donahue PR,Wogan GN

    更新日期:1992-01-15 00:00:00

  • Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.

    abstract::In eight estrogen receptor (ER)-positive breast cancer cell lines (including three sublines of MCF-7) and five ER-negative breast lines, the action of the nonsteroidal antiestrogen, tamoxifen, was studied, and the concentrations of ER and antiestrogen binding site were measured. The concentration of antiestrogen bindi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddel RR,Murphy LC,Hall RE,Sutherland RL

    更新日期:1985-04-01 00:00:00

  • Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.

    abstract::The potential of transforming growth factor-alpha (TGF-alpha) to function as an autocrine growth factor was evaluated in numerous ovarian carcinoma cell lines. All 17 lines which were examined expressed the epidermal growth factor receptor and 16 cell lines, in addition, concomitantly secreted TGF-alpha. Radioimmunoas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Stromberg K,Collins TJ 4th,Gordon AW,Jackson CL,Johnson GR

    更新日期:1992-01-15 00:00:00

  • Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

    abstract::Analysis of ovarian carcinomas has shown that karyotypes are often highly abnormal and cannot be identified with certainty by conventional cytogenetic methods. In this study, 17 tumors derived from 13 patients were analyzed by a combination of spectral karyotyping (SKY), comparative genomic hybridization (CGH), and ex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bayani J,Brenton JD,Macgregor PF,Beheshti B,Albert M,Nallainathan D,Karaskova J,Rosen B,Murphy J,Laframboise S,Zanke B,Squire JA

    更新日期:2002-06-15 00:00:00

  • Diet, nutrition, and cancer: the future of dietary policy.

    abstract::The long latency period of cancer would suggest that timely measures to reduce the risk of cancer, such as dietary guidelines to the public, be an integral component of policy on cancer. Although criteria for acceptability of scientific evidence are often defined, judgment its required in interpreting the significance...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Palmer S

    更新日期:1983-05-01 00:00:00

  • EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

    abstract::The EphA2 receptor tyrosine kinase is found at low levels on nontransformed adult breast epithelial cells but is frequently overexpressed on aggressive breast cancer cells. Recent studies have documented an inverse relationship between EphA2 and estrogen receptor expression in breast cancer cell lines. In our present ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu M,Miller KD,Gokmen-Polar Y,Jeng MH,Kinch MS

    更新日期:2003-06-15 00:00:00

  • Adaptive therapy.

    abstract::A number of successful systemic therapies are available for treatment of disseminated cancers. However, tumor response is often transient, and therapy frequently fails due to emergence of resistant populations. The latter reflects the temporal and spatial heterogeneity of the tumor microenvironment as well as the evol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-3658

    authors: Gatenby RA,Silva AS,Gillies RJ,Frieden BR

    更新日期:2009-06-01 00:00:00

  • Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.

    abstract::Earlier studies (Baeckström et al., J. Biol. Chem., 266: 21537-21547, 1991) have revealed that the colon carcinoma cell line COLO 205 produces two different proteins carrying the carcinoma-associated sialyl-Le(a) carbohydrate epitope. One is the MUC1 mucin apoprotein, and the other protein is smaller and has not been ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Baeckström D,Nilsson O,Price MR,Lindholm L,Hansson GC

    更新日期:1993-02-15 00:00:00

  • Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.

    abstract::Pancreatic cancer is an aggressive neoplasm with no current viable, effective treatment options. In the majority of cases, at first diagnosis, pancreatic cancer has already become metastatic so that conventional treatment regimens provide minimal, if any, clinical benefit in prolonging life or ameliorating the negativ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1261

    authors: Sarkar D,Su ZZ,Vozhilla N,Park ES,Randolph A,Valerie K,Fisher PB

    更新日期:2005-10-01 00:00:00